Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.01	0.03	0.58
Cash & Short-Term Investments	0.01	0.03	0.58
Cash Growth	-	-95.14%	-
Prepaid Expenses	0	0	-
Total Current Assets	0.01	0.03	0.58
Other Long-Term Assets	43.59	73.78	69.89
Total Assets	43.6	73.81	70.47
Accrued Expenses	0.46	0.3	0.02
Short-Term Debt	0.76	0.23	-
Other Current Liabilities	0.47	0.29	-
Total Current Liabilities	1.69	0.82	0.02
Other Long-Term Liabilities	44.28	74.47	70.58
Total Liabilities	45.97	75.29	70.6
Common Stock	0	0	0
Retained Earnings	-2.37	-1.48	-0.13
Shareholders' Equity	-2.37	-1.48	-0.13
Total Liabilities & Equity	43.6	73.81	70.47
Total Debt	0.76	0.23	-
Net Cash (Debt)	-0.75	-0.2	0.58
Net Cash Per Share	-	-0.02	0.26
Filing Date Shares Outstanding	-	8.03	9.03
Total Common Shares Outstanding	-	9.03	9.03
Working Capital	-1.68	-0.79	0.56
Book Value Per Share	-	-0.16	-0.01
Tangible Book Value	-2.37	-1.48	-0.13
Tangible Book Value Per Share	-	-0.16	-0.01

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q